Sorry, you need to enable JavaScript to visit this website.
Skip to main content
Home

Header Top Menu

  • News & Featured Stories
  • Media
  • Careers
  • Contact Us
  • Our Science

    Sub Menu 1

    • Pfizer in the UK
      • Our History
      • Pharmaceutical Sciences
      • Devices Centre of Excellence
      • Global Regulatory Affairs
      • Material Characterisation Team
      • Anti-Counterfeit Laboratory
    • Our Therapy Areas
      • Anti-Infectives
      • Inflammation and Immunology
      • Internal Medicine
      • Oncology
      • Rare Disease
      • Vaccines

    Sub Menu 2

    • Developing New Medicines
      • Clinical Trials
      • Pipeline
    • Research partnerships
      • ADDoPT
      • Innovative Target Exploration Network (ITEN)
      • INSPIRE Programme
      • Medical Research Council Collaboration
      • The Stratified Medicine Programme
      • Partnership with Regeneron for UK Biobank exome sequencing
    • Breakthroughs that change patients’ lives
    Hot Topic

    Re-shaping Cancer

    Re-shaping cancer
  • Products

    Sub Menu 4

    • Prescription medicines

    Sub Menu 5

    • Safety of Medicines
      • Medicines Regulation
      • Reporting Side Effects
      • Counterfeit Medicines
    Hot Topic

    Vaccines partnerships

    Vaccines partnerships
  • Responsibility

    Sub Menu 7

    • Transparency
      • HCP & HCO Annual Disclosure Reports
      • Healthcare Organisation Grants
      • Research and Development Funding
      • Patient Organisation Funding and Support
    • Codes of Conduct
      • Gender Pay Gap Report
      • Section 172 Statements
      • Pfizer UK Modern Slavery Statement
      • Pfizer UK Tax Strategy

    Sub Menu 8

    • Environmental Sustainability
      • Climate Action
      • Global Actions
      • Our Partnerships & Commitments
      • Sustainable Medicines
      • UK Actions
    • Insurance Details
    • Animal Welfare
    Hot Topic

    Putting Patients First

    Putting Patients First
  • UK Society

    Sub Menu 10

    • Social Investment
      • Volunteering and Fundraising
      • Medicines Donations
    • Raising Public Awareness
      • Change the Course
      • Pfizer Sponsors Science Museum Group's 'Cancer Revolution' Exhibition
      • Pfizer Sponsors the Superhero Series
      • Pfizer sponsors Science Museum exhibition 'Superbugs'
      • Pfizer at the British Science Festival
      • Turning Heads at Westminster

    Sub Menu 11

    • Science Education
      • Developing Science Talent
      • 'Superbugs Join The Fight' School Programme
      • Online Learning
        • Student Education Area
        • Teacher Resources
      • Community Lab
      • Career Talks
      • Lab in a Box
    • Pfizer Worldwide
      • Global Health Fellows
      • Global Aid and Emergency Relief
      • International Trachoma Initiative
    Hot Topic

    'Superbugs' Competition Winners

    Superbugs Winners
  • UK Health System

    Sub Menu 16

    • Working with the NHS and other Healthcare Organisations
      • Collaborative Working
        • Collaborative Working Project between Lloyds Pharmacy and Pfizer Vaccines
        • Joint Working
      • Donations and Grants
        • Independent Medical Grants and Donations
        • Donations of Goods, Services and Benefit in Kind
        • Grants
        • Donations and Grants Enquiry Form
    • Working with Healthcare Professionals
      • FAQs: Working with Healthcare Professionals
      • Pharmacy
      • Healthcare Professionals Congress Sponsorship

    Sub Menu 17

    • Working with Patient Organisations
      • Patient Involvement in Research and Development
      • Our ongoing partnership with the UK Sepsis Trust
      • Partnering with the NIHR and young people on clinical research
    • Pfizer Healthcare Hub
      • Pfizer Healthcare Hub: 2018
      • Pfizer Healthcare Hub: 2017
      • Connect with the Hub
    Hot topic

    Osteoarthritis

    Osteoarthritis
  • News & Featured Stories
  • Media
  • Careers

    Carrers

    • Search Current Vacancies
    • Apprenticeships
      • Apprenticeship Vacancies
    • Undergraduate Placements
      • Undergraduate Vacancies
    • Meet our people
    • UK Top Employer
    • How Pfizer is fostering meaningful growth for every colleague, everywhere
  • Contact Us
  • Footer links

    Footer mobile menu

    • Footer Menu
    • Footer menu
      • Contact Us
      • Cookie Policy
      • Terms of Use
      • Privacy Policy
      • Sitemap
    • Footer social item
      • Facebook
      • Twitter
      • Instagram
      • YouTube

Pfizer pledges to support Government’s 2030 smoke free ambition

Pfizer pledges to support Government’s 2030 smoke free ambition
News & Featured Stories/ Pfizer pledges to support Government’s 2030 smoke free ambition
11/03/2020

Ben Osborn
Country Manager, Pfizer UK

Today (11th March), marks National No Smoking Day, an important milestone on which we can focus our efforts as a society to help people quit smoking. This is now more important than ever, as last year the Government set an ambitious goal for England to be smoke free by 2030.

 

Which is why, on National No Smoking Day, we pledge to do everything we can to help people lead healthier, longer lives and reduce the burden on the NHS. I feel very passionate about the importance of new approaches to prevention for the UK population and the NHS, as I truly believe it can make a difference. If we can encourage every smoker who has contact with the NHS to stop smoking, we can help prevent ill health and reduce demands on the healthcare system. That way, we can protect the NHS as a treasured national resource, while also protecting society from disease.

The negative health impacts of smoking are well known. The NHS and public health bodies have made significant efforts to reduce tobacco use through the introduction of stop smoking services, smoking control measures and public awareness campaigns.

Great progress has been made in moving towards a smoke-free society and the UK now has one of the lowest smoking rates in Europe with fewer than 1 in 6 adults smoking.1 There is still more to be done however, with 489,300 hospital admissions and sadly 77,800 deaths reported in 2017 linked to smoking.2

Additionally, smoking is often highly correlated with geographical health and socio-economic inequalities. As the new Government delivers its first budget today, there would be a welcome focus on levelling up economic prosperity across the country.

As the NHS and Government have acknowledged, there is a significant opportunity in encouraging people to stop smoking via their everyday use of the health service.

Great progress has been made in moving towards a smoke-free society and the UK now has one of the lowest smoking rates in Europe with fewer than 1 in 6 adults smoking." 

People come into contact with the NHS at some of the most vulnerable moments in their lives. They are unwell already - yet often exacerbate risks by continuing to smoke.

These interactions with a healthcare system are genuine ‘teachable moments’ for people with significant health risk factors like smoking.

We’re currently working with the NHS in Manchester on a joint working project as part of their CURE programme which is aimed at curing tobacco addiction through interventions in the hospital setting.

Through effective targeted advice from a healthcare professional, licensed therapeutic intervention  and ongoing stop smoking support, people are more likely to quit.

These hospital-based interventions could make a significant contribution to reaching the smoke-free 2030 goal and as a leading healthcare organisation we can help to support their introduction. More broadly, these types of initiatives would also help to contribute to the NHS’s long-term plan by reducing the number of deaths which occur due to cardiovascular disease.

So, on No Smoking Day we pledge to support the 2030 smoke-free ambition. In order to make the UK healthier and support our NHS, we must all play our part in this important public health initiative.

 

References

  1. GOV UK. Advancing our health: prevention in the 2020s – consultation document Accessed Nov 2021
  2. NHS UK. Statistics on Smoking, England - 2019 Accessed Nov 2021

 

PP-PFE-GBR-4219 / November 2021

Related Hot Topics
AMR Reimbursement Pilot Launch
World First Cross-Industry Initiative Launches in the Continued Fight Against…
VacciNation report
VacciNation: tackling health inequalities across England
Patients at heart of clinical trials
Why putting patients at the heart of Pfizer UK’s clinical trials continues to…
Infection Management Coalition Paper
Cross-Industry Coalition Tackling ‘Hidden Pandemic’ of Antibiotic Resistant…
Blueprint for gene therapy adoption
Pfizer UK launch blueprint for the UK adoption of cell and gene therapies
Inhealthcare
Inhealthcare: where are they now?
Osteoarthritis
Osteoarthritis: It’s time to talk about mental health
The Power of Vaccines
The Power of Vaccines in a Post-Pandemic World
Tags
UK Health System

Footer

  • Contact Us
  • Cookie Policy
  • Terms of Use
  • Privacy Policy
  • Sitemap

Footer aside

  • Footer Aside
    • Facebook
    • Twitter
    • Instagram
    • YouTube

Copyright © 2017-2022 Pfizer Limited. PP-PFE-GBR-4248 / Nov 2021. All rights reserved. Registered in England and Wales No. 526209. Registered office: Ramsgate Road, Sandwich, Kent CT13 9NJ. VAT No. GB201048427